28 – 30 April 2023 – Dubrovnik, Croatia
| 14:00 – 17:00 | Participants’ check-in and registration |
| 19:00 – 22:00 | Welcome dinner at the hotel restaurant Lenga |
| 09:00 – 09:15 | Welcome Lise-lott Eriksson, President of MPE | |
| 09:15 – 10:30 | Plenary session 1 – Myeloma and AL amyloidosis treatment updates Prof. Dr. Moshe Gatt, Director, Hematology department, Hadassah Hebrew University Medical Center, Jerusalem | |
| 10:30 – 10:45 | Coffee break | |
| 10:45 – 11:45 | Plenary session 2 – Health Technology Assessment (HTA) Dr Neil Bertelsen, Steering Committee Member/Past Chair HTAi PCIG MPE Member presentations Emma Andersson, Association of Cancer Patients in Finland Varda Shoham, AMEN, Israel | |
| 11:45 – 12:00 | Coffee break | |
| 12:00 – 13:00 | Plenary session 3 – CAR-T Dr Charlotte Pawlyn, PhD, Haematologist and Clinician Scientist, Cancer Research UK | |
| 13:00 – 13:05 | Morning session close | |
| 13:05 – 14:15 | Lunch break | |
| 14:15 – 15:15 | Breakout session 1 – Improving access to clinical trials in Central and Eastern Europe (CEE) Moderator: Biljana Shrepfler (Biba), BORKA, Macedonia Speakers: Prof. Dr Roman Hajek, Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic Prof. Dr Oliver Karanfilski, University Clinic for Hematology, Skopje, Republic of North Macedonia Dr Sandra Bašić Kinda, University Hospital Centre Zagreb, Croatia Barbara Leonardi, MPE member, Carita, Poland | Breakout session 2 – Effective running of Facebook support groups Zvika Zilberman, AMEN, Israel |
| 15:15 – 16:00 | Coffee break Poster presentations Member programmes, success stories and MPE projects MPE members and MPE team | |
| 16:00 – 17:00 | Breakout session 3 – Funding Livija Rojc Štremfelj, Agencija LARS, Institution for culture, education and consulting, Cerkno, Slovenia MPE Member presentation Kristina Modic, L&L, Slovenia | Breakout session 4 – Press relations and media engagement Marion Sauvebois, Myeloma UK Ana Vallejo, MPE MPE Member presentation Łukasz Rokicki, Carita, Poland |
| 17:00 – 17:05 | Day one close | |
| 19:00 – 22:00 | Offsite dinner |
| 09:00 – 09:10 | Welcome |
| 09:10 – 10:10 | Plenary Session 4 – Importance of physical fitness for myeloma and AL amyloidosis patients and the impact on their Quality of Life (QoL) Dr. Orla McCourt, University College London Hospitals NHS Foundation Trust, UK MPE Member presentation Milica Kuzmanoska, HEMA-ONKO, Macedonia |
| 10:10 – 10:30 | Coffee break |
| 10:30 – 10:45 | Plenary session 2 – Health Technology Assessment (HTA) Dr Neil Bertelsen, Steering Committee Member/Past Chair HTAi PCIG MPE Member presentations Emma Andersson, Association of Cancer Patients in Finland Varda Shoham, AMEN, Israel |
| 10:45 – 12:00 | Coffee break |
| 12:00 – 12:10 | Plenary session 3 – CAR-T Dr Charlotte Pawlyn, PhD, Haematologist and Clinician Scientist, Cancer Research UK |
| 12:10 – 12:45 | Morning session close |
| 12:45 – 13:00 | Lunch break |
| 13:00 – 14:00 | Breakout session 1 – Improving access to clinical trials in Central and Eastern Europe (CEE) Moderator: Biljana Shrepfler (Biba), BORKA, Macedonia Speakers: Prof. Dr Roman Hajek, Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic Prof. Dr Oliver Karanfilski, University Clinic for Hematology, Skopje, Republic of North Macedonia Dr Sandra Bašić Kinda, University Hospital Centre Zagreb, Croatia Barbara Leonardi, MPE member, Carita, Poland |